Angel Alberich-Bayarri (@aalberich) 's Twitter Profile
Angel Alberich-Bayarri

@aalberich

Founder & CEO of @QuibimBiomarker. Dad of 3. Born and raised in Spain.

ID: 46243971

linkhttp://www.quibim.com calendar_today10-06-2009 22:27:18

2,2K Tweet

1,1K Followers

1,1K Following

Quibim (@quibimbiomarker) 's Twitter Profile Photo

Stepping into 2025, let’s talk about your liver—one of your body’s most vital organs. #NAFLD affects 38% of the global population, and research even highlights sugary drinks as a significant contributor to the risk of #livercancer and chronic illnesses. Protect your liver: ▪️

Stepping into 2025, let’s talk about your liver—one of your body’s most vital organs. #NAFLD affects 38% of the global population, and research even highlights sugary drinks as a significant contributor to the risk of #livercancer and chronic illnesses.

Protect your liver:
▪️
AuntMinnieEurope (@auntminnieeuro) 's Twitter Profile Photo

The #medicalimaging community has started to give its verdict on the UK government's 26-page strategy document for AI that was unveiled on 13 January. buff.ly/42iBHnX #radiology #healthtech Signify Research Angel Alberich-Bayarri Quibim

Quibim (@quibimbiomarker) 's Twitter Profile Photo

Thrilled to announce the successful closure of our $50M Series A. This funding propels our mission to redefine #medicalimaging and transform #healthcare. Huge thanks to our team and partners—together, we’re improving health outcomes worldwide. lnkd.in/dSG2DnaS

GoHub Ventures (@gohubventures) 's Twitter Profile Photo

We're proud to be part of Quibim's $50 million Series A funding round 🙌 🩺 The Valencia-based company led by Angel Alberich-Bayarri, is on a mission is to turn imaging into a catalyst for precision health through #AI Read more 🔗 gohub.vc/quibim-50m-ser…

We're proud to be part of <a href="/QuibimBiomarker/">Quibim</a>'s $50 million Series A funding round 🙌

🩺 The Valencia-based company led by <a href="/aalberich/">Angel Alberich-Bayarri</a>, is on a mission is to turn imaging into a catalyst for precision health through #AI

Read more 🔗 gohub.vc/quibim-50m-ser…
Kfund (@kfundvc) 's Twitter Profile Photo

Exciting news! Quibim has closed a $50M Series A to transform medical processes with AI-powered imaging. We’re proud to support Angel Alberich-Bayarri and his team as they advance precision medicine! kfund.vc/post/quibim-ra…

Tony Fadell (@tfadell) 's Twitter Profile Photo

Turning medical images into actionable data- Quibim is using Artificial Specific Intelligence to analyze medical imaging with precision, detect disease early, and improve treatment outcomes. From detecting subtle changes in brain structure for early Alzheimer's

Tony Fadell (@tfadell) 's Twitter Profile Photo

6/7 I've been in the trenches long enough to know the difference between hype and real innovation. Artificial Specific Intelligence is the way forward. Cc: Build Collective companies doing it right: Plumerai Orionis Biosciences Quibim Nabla Smartex

Javier Pastor (@javipas) 's Twitter Profile Photo

Pasé un rato muy interesante con Angel Alberich-Bayarri hablando de cómo la IA puede ayudar (y mucho) en el diagnóstico médico. Aquí está el resultado.

GoHub Ventures (@gohubventures) 's Twitter Profile Photo

Why did we invest in Quibim? ⤵ 💪 Strong team led by Angel Alberich-Bayarri 🩻 It's transforming precision medicine with #AI imaging biomarkers 🤝 Partnerships with industry leaders in biopharma 🗃 Own medical imaging dataset: QP Insights Read more ➡ gohub.vc/ai-precision-m…

Why did we invest in <a href="/QuibimBiomarker/">Quibim</a>? ⤵

💪 Strong team led by <a href="/aalberich/">Angel Alberich-Bayarri</a>
🩻 It's transforming precision medicine with #AI imaging biomarkers
🤝 Partnerships with industry leaders in biopharma
🗃 Own medical imaging dataset: QP Insights

Read more ➡ gohub.vc/ai-precision-m…
UVocupació (@uvocupacio) 's Twitter Profile Photo

🎯La innovació en el sector salut, a debat al #FòrumOcupació! 🗣 Ana Blanco Sánchez, Dir d'ajudes i innovació a QUIBIM, explica com la tecnologia està transformant el diagnòstic mèdic i la recerca en imatge biomèdica Una ponència imprescindible per entendre el futur del sector!

🎯La innovació en el sector salut, a debat al #FòrumOcupació!

🗣 Ana Blanco Sánchez, Dir d'ajudes i innovació a QUIBIM, explica com la tecnologia està transformant el diagnòstic mèdic i la recerca en imatge biomèdica

Una ponència imprescindible per entendre el futur del sector!
CEEI Valencia (@ceeivalencia) 's Twitter Profile Photo

La valenciana Quibim ha obtenido la autorización en EE.UU. para su software QP-Prostate CAD, que ayuda a detectar el cáncer de próstata con IA. Un paso clave para su comercialización a escala internacional. ¡Enhorabuena, Angel Alberich-Bayarri y equipo! 👏 valenciaplaza.com/valenciaplaza/…

Mario Nawfal (@marionawfal) 's Twitter Profile Photo

🇦🇷 MILEI’S ADVISOR: ARGENTINA EYES AI + NUCLEAR FUTURE Dr. Reidel, Demian Reidel: “We want to be an AI hub—and a commercially nuclear energy country. We’ll probably be one of the first countries with a commercially available SMR solution."

GoHub Ventures (@gohubventures) 's Twitter Profile Photo

🆕 Quibim's QP-Prostate® CAD receives FDA 510(k) clearance The company's flagship solution leverages #AI to reveal hidden aggressive prostate cancer lesions 🔬 Congrats Angel Alberich-Bayarri & team on this incredible milestone! 🎉 quibim.com/newsroom/news-…

Quibim (@quibimbiomarker) 's Twitter Profile Photo

🏆 We’re thrilled to share that Quibim has secured 3rd place in the 50-100 employees category of Spain’s #BestWorkplaces25! This recognition by Great Place to Work Spain reflects our commitment to a people-first culture and workplace well-being. A huge thank you to our incredible team—let’s

🏆 We’re thrilled to share that Quibim has secured 3rd place in the 50-100 employees category of Spain’s #BestWorkplaces25!

This recognition by <a href="/GPTW_Spain/">Great Place to Work Spain</a> reflects our commitment to a people-first culture and workplace well-being.

A huge thank you to our incredible team—let’s
Operador Nuclear (@operadornuclear) 's Twitter Profile Photo

El presidente del Gobierno, Pedro Sánchez, miente sobre las centrales nucleares o demuestra su ignorancia sobre tecnología eléctrica al acusarlas de empeorar el apagón del 28 de abril de 2025. Las centrales nucleares aportan inercia al sistema eléctrico, ayudando a evitar

Operador Nuclear (@operadornuclear) 's Twitter Profile Photo

«Las centrales nucleares a pleno funcionamiento habrían hecho el apagón menos probable». Mi entrevista en Crónica Global cronicaglobal.elespanol.com/vida/20250429/…

IVF (@gvaivf) 's Twitter Profile Photo

👏Enhorabuena Quibim 🏆Quibim, que cuenta con #ApoyofinancieroIVF, ha sido galardonada en los premios otorgados en la 27ª Noche de las Telecomunicaciones Valencianas. 🫂La consellera GVA Hisenda Ruth Merino fue la encargada de hacer entrega de este reconocimiento.

👏Enhorabuena <a href="/QuibimBiomarker/">Quibim</a> 

🏆Quibim, que cuenta con #ApoyofinancieroIVF, ha sido galardonada en los premios otorgados en la 27ª Noche de las Telecomunicaciones Valencianas.

🫂La consellera <a href="/GVAhisenda/">GVA Hisenda</a> <a href="/rut_merino/">Ruth Merino</a> fue la encargada de hacer entrega de este reconocimiento.
Quibim (@quibimbiomarker) 's Twitter Profile Photo

The 13th European Society of Urogenital Radiology prostate MRI course is being held today in Cambridge. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer.

The 13th <a href="/EsurOffice/">European Society of Urogenital Radiology</a> prostate MRI course is being held today in Cambridge. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer.
ESMO Open (@esmo_open) 's Twitter Profile Photo

A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer in ESMO Open. A new “Risk Stratification”score based on clinical/pathological and radiomics features outperforming conventional methods. esmoopen.com/article/S2059-…

A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer in <a href="/ESMO_Open/">ESMO Open</a>. A new “Risk Stratification”score based on clinical/pathological and radiomics features outperforming conventional methods. esmoopen.com/article/S2059-…